Literature DB >> 30814120

A tangled tale of molecular subtypes in pancreatic cancer.

Shiv Singh1, Marie Christin Hasselluhn1, Albrecht Neesse1.   

Abstract

Entities:  

Keywords:  molecular subtype; pancreatic ductal adenocarcinoma; precision medicine; stroma

Mesh：

Substances：

Year:  2019        PMID： 30814120     DOI： 10.1136/gutjnl-2018-318086

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer.

Authors:  Mengyu Tu; Lukas Klein; Elisa Espinet; Theodoros Georgomanolis; Florian Wegwitz; Xiaojuan Li; Laura Urbach; Adi Danieli-Mackay; Stefan Küffer; Kamil Bojarczuk; Athanasia Mizi; Ufuk Günesdogan; Björn Chapuy; Zuguang Gu; Albrecht Neesse; Uday Kishore; Philipp Ströbel; Elisabeth Hessmann; Stephan A Hahn; Andreas Trumpp; Argyris Papantonis; Volker Ellenrieder; Shiv K Singh
Journal:  Nat Cancer       Date:  2021-11-15

2.  Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer.

Authors:  Niklas Krebs; Lukas Klein; Florian Wegwitz; Elisa Espinet; Hans Carlo Maurer; Mengyu Tu; Frederike Penz; Stefan Küffer; Xingbo Xu; Hanibal Bohnenberger; Silke Cameron; Marius Brunner; Albrecht Neesse; Uday Kishore; Elisabeth Hessmann; Andreas Trumpp; Philipp Ströbel; Rolf A Brekken; Volker Ellenrieder; Shiv K Singh
Journal:  JCI Insight       Date:  2022-08-22

3.  CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer.

Authors:  Zixuan Zhou; Zuyi Ma; Zhenchong Li; Hongkai Zhuang; Chunsheng Liu; Yuanfeng Gong; Shanzhou Huang; Chuanzhao Zhang; Baohua Hou
Journal:  J Cancer       Date:  2021-08-03       Impact factor: 4.207
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.